Clinical trials
Every registered trial of Daptomycin
113 studies, 7 still enrolling.
Plain-Language Summary
Plain-language reading of the public trial registries.
In short
- Daptomycin has a real but limited body of human research.
- 113 registered studies in total.
- 7 are still enrolling people, so this is active research, not just history.
What kind of research
- 98 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
- About 22,640 people took part in those.
- A further 15 studies only looked at records of people already taking it. These are counted separately because nobody was given the peptide for the study, so they cannot prove cause and effect.
How far along it is
- 51 trials have reached phase 3 or 4 — the large, late-stage trials regulators rely on to approve a drug.
- 28 have published results in the medical literature that anyone can read.
- The research spans 35 countries.
A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.
Filter
Showing 113 of 113 trials for Daptomycin.
22-CONS-01
Centre Hospitalier Universitaire De Nice
Osteoarticular infections on equipment
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Combination Antibiotic Therapy for Staphylococcus Aureus Bacteremia
Intermountain Health Care, Inc.
Staphylococcus Aureus Bacteremia
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Does Staphylococcus Aureus Bacteremia Early Dual Therapy Improve Outcomes?
West Virginia University
Staphylococcus Aureus Bacteremia
Efficacy of seven and fourteen days of antibiotic treatment in uncomplicated Staphylococcus aureus bacteremia: A randomized, non-blinded, non-inferiority interventional study
Hvidovre Hospital
Staphylococcus aureus bacteremia
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
In Vivo Antibiotics Removal During Hemoadsorption Cartridges and Continuous Renal Replacement Therapy in the Intensive Care Unit
Niguarda Hospital
Septic Shock
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Daptomycin vs. Vancomycin for the Treatment of Methicillin Resistant S. Aureus Bacteremia
Todd C. Lee MD MPH FIDSA
Staphylococcus Aureus Septicemia · Staphylococcus Aureus Bacteremia · S. Aureus Bacteremia · S. Aureus Bloodstream Infection
Adjunctive Fosfomycin for Treatment of Staphylococcus Aureus Bacteraemia
Hospital Universitari de Bellvitge
Staphylococcus Aureus Bacteremia
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Endocarditis, Infective
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Preoperative Daptomycin Prophylaxis in Two-Stage Exchange Arthroplasty: A Prospective, Randomized, Double-Blinded Trial
Chang Gung Memorial Hospital
Periprosthetic Joint Infection
INTENSE
Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
Uncomplicated bacteremia caused by E. faecalis or E. faecium.
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
DURATIOM
Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevilla
Patients with an infection of the osteosynthesis material implanted after a long bone fracture, who are treated by surgical debridement with retention of the implant plus targeted antimicrobial therapy or by surgical debridement with removal of the material. These patients have the osteosynthesis material implanted to stabilize and help heal the fracture and who meet the criteria for Infections associated with the osteosynthesis material. -arm without/with removal MO: 256/108pac (364pac)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Staphylococcus aureus Network Adaptive Platform trial (SNAP)
University Medical Center Utrecht
Staphylococcus aureus bacteremia
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Comparing Oral Versus Parenteral Antimicrobial Therapy
West Virginia University
Endovascular Infection · Bone and Joint Infection · Skin and Soft Tissue Infection · Pulmonary Infection
APHP220763
Assistance Publique Hopitaux De Paris
Catheter related bloodstream infections due to Staphylococcus aureus
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Staphylococcus Aureus Network Adaptive Platform Trial
University of Melbourne
Staphylococcus Aureus Bacteremia
Accelerated treatment of infectious endocarditis
Region Skane
Infectious endocarditis
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Utility Assessment of a Pharmacy-to-Dose Daptomycin
Methodist Health System
Antibiotics Causing Adverse Effects in Therapeutic Use
PHASE II SINGLE-CENTER, RANDOMIZED, OPEN-LABEL, PROSPECTIVE, STUDY TO DETERMINE THE IMPACT OF SERIAL PROCALCITONIN
M.D. Anderson Cancer Center
Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm
Pharmacokinetics and Toxicodynamics of Daptomycin in Bone and Joint Infections
Hospices Civils de Lyon
Dactinomycin Adverse Reaction · Bone and Joint Infection
DOTS: Dalbavancin as an Option for Treatment of Staphylococcus Aureus Bacteremia
National Institute of Allergy and Infectious Diseases (NIAID)
Staphylococcal Bacteraemia
Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)
Hospital Universitari de Bellvitge
Hemodiafiltration · Sepsis · Acute Kidney Injury
A Pharmacokinetics Study of Daptomycin in Critically Ill Patients and Effects of Daptomycin on Kidney
Zhongnan Hospital
Outcome, Fatal · Infection
Subcutaneous Daptomycin in Healthy Volunteers (DAPTOSC)
University Hospital, Caen
Antibiotics · Subcutaneous Injection · Daptomycin
The Efficacy and Safety of Daptomycin in the Treatment of Gram-positive Bacterial Infection.
Jiangsu Hengrui Pharmaceutical Co., Ltd.
Antibiotic
Study of antimicrobial resistance in patients receiving outpatient parenteral antimicrobial therapy
Cambridge University Hospitals NHS Foundation Trust
Antimicrobial resistance (AMR)
Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)
Azienda Sanitaria-Universitaria Integrata di Udine
Therapeutic Drug Monitoring · Subarachnoid Hemorrhage · Intracerebral Hemorrhage
Ceftriaxone as Home IV for Staph Infections
Vancouver Island Health Authority
Staphylococcal Infections · Osteomyelitis · CNS Infection · Septic Arthritis
Description of Eosinophilic Pneumonia in BJI/PJI Treated by Daptomycin
Hospices Civils de Lyon
Dactinomycin Adverse Reaction · Bone and Joint Infection
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
Merck Sharp & Dohme LLC
Bacteremia · Soft Tissue Infections · Skin Diseases, Infectious
Ceftobiprole in the Treatment of Patients With Staphylococcus Aureus Bacteremia
Basilea Pharmaceutica
Staphylococcus Aureus Bacteremia
Adjunction of Daptomycin for the Treatment of Pneumococcal Meningitis
Centre Hospitalier Universitaire Dijon
Pneumococcal Meningitis
Real-world Daptomycin Use in Chinese ICUs
West China Hospital
Daptomycin · Real-world Study · Intensive Care Unit
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Dalbavancin For The Treatment of Gram Positive Osteoarticular Infections
Infectious Diseases Physicians, Inc.
Bone Infection · Osteomyelitis · Septic Arthritis · Joint Infection
Daptomycin as Adjunctive Therapy for Staphylococcus Aureus Bacteremia
McGill University Health Centre/Research Institute of the McGill University Health Centre
Methicillin Susceptible Staphylococcus Aureus Septicemia · Bacteremia
Daptomycin Concentration in Drainage Fluid and Blood Samples of ICU Patients
University Hospital Tuebingen
Heart Assist Device
Retrospective Analysis of Nephrotoxicity During Daptomycin Versus Vancomycin Treatments in High Risk Patients
University Hospital, Montpellier
Infective Endocarditis · Infection Related to Ventricular Assist Device · Infection Related to Vascular Prothesis · Surgical Site Infection
IL-10 Stratifying Tool for Towards Antibiotic Selection for MRSaB
Sharp HealthCare
Bacteremia
Population Pharmacokinetics of Anti-infectives in Critically Ill Children
Assistance Publique - Hôpitaux de Paris
Pediatric Intensive Care Unit · Pediatric Immuno-hematology Department
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock
Zhongda Hospital
Septic Shock
A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial
Cumberland Pharmaceuticals
Bacteremia
Evaluation of Single-dose Pharmacokinetics of Intravenous Daptomycin in Patients With Thermal Injury
University of Zurich
Burn Injury
Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin
University of Utah
Drug Interactions · Pharmacokinetics
Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis
Loyola University
Osteomyelitis
Population Pharmacokinetic (PK) Study of Multiple Doses of Cubicin® (Daptomycin) 10 mg/kg in Critical Care Patients Having Bacteremia, Endocarditis or Skin Soft Tissue Infections Due to Gram Positive Bacteria With Various Degrees of Renal Failure
Poitiers University Hospital
Renal Failure · Critical Care · Gram Positive Bacteria
Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections
Cellceutix Corporation
Skin Infection · Bacterial Infection
Vancomycin Versus Daptomycin for the Treatment of Methicillin Resistant Staphylococcus Aureus (MRSA) Bacteremia
Singapore General Hospital
Bacteremia Due to Staphylococcus Aureus
Staphylococcus Aureus Bacteremia Antibiotic Treatment Options
Heinrich-Heine University, Duesseldorf
Staphylococcus Aureus Infection
Efficacy of Daptomycin Plus Fosfomycin Versus Daptomycin for Treatment of MRSA Bacteremia
Miquel Pujol
Staph Aureus Methicillin Resistant Bacteremia
Safety and Efficacy Study of Daptomycin Compared to Active Comparator in Pediatric Participants With Acute Hematogenous Osteomyelitis (AHO) (MK-3009-006)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Acute Hematogenous Osteomyelitis
Pharmacokinetics Study of Intraperitoneal Administration of Daptomycin in Peritoneal Infection
University Hospital, Caen
Peritoneal Infection
Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection
Arrevus Inc.
Prosthetic Joint Infections of Hip · Prosthetic Joint Infections of Knee · Infected Spacers
Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Bacteremia
The Effects of Daptomycin and Cytokines Production in Comparison With Vancomycin
Hospital Universitario Evangelico de Curitiba
Cellulitis
Daptomycin With Rifampin for Treatment of Staphylococcal Prosthetic Joint Infection
Andrej Trampuz
Staphylococcal Infections
Daptomycin Versus Vancomycin in the Treatment of Nosocomial or Healthcare-associated MRSA Bacteremia
Assistance Publique - Hôpitaux de Paris
Nosocomial Infection · Healthcare-associated Infection
Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections
University of Cincinnati
Cellulitis · Skin Infections
Concentration of Antimicrobials in Catheter-lock Solutions
Clinica Universidad de Navarra, Universidad de Navarra
Catheter-Related Infections · Bacteremia.
Daptomycin in Pediatric Patients With Bacterial Meningitis
Insel Gruppe AG, University Hospital Bern
Meningitis
Clinical Usefulness of Mic/Breakpoint Ratio and Penetration in Tissues. A Prospective Study of Clinical Validation
Federico II University
Infection of Skin and/or Subcutaneous Tissue
Safety and Efficacy of Strategy to Prevent Drug-Induced Nephrotoxicity in High-Risk Patients
Henry Ford Health System
Health Care Associated Pneumonia · Osteomyelitis/Septic Arthritis · Endocarditis · Bacteremia
Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Staphylococcal Skin Infections
Application of Daptomycin in MRSA Infected Diabetic Foot in Comparison to Vancomycin Treatment
Ruhr University of Bochum
Diabetic Foot
Vancomycin Versus Daptomycin for the Treatment of Methicillin-resistant Staphylococcus Aureus Bacteremia Due to Isolates With High Vancomycin Minimum Inhibitory Concentrations (MICs)
St. John Health System, Michigan
Bacteremia
Daptomycin Versus Placebo in Patients With Neutropenia and Fever
University of Rochester
Febrile Neutropenia
Treatment Algorithm to Reduce the Use of Vancomycin in Adults With Blood Stream Infection
Duke University
Bacteremia
Daptomycin > 6 mg/kg/day in complex bone and joint infection
Hospices Civils de Lyon
Complex bone and joint infection
Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis
University of Padova
Cirrhosis · Ascites · Nosocomial Spontaneous Bacterial Peritonitis
Daptomycin Use for Antimicrobial Prophylaxis in Methicillin Resistant Staphylococcus Aureus (MRSA) Colonized Adult Patients Undergoing Primary Elective Hip, Knee, or Shoulder Arthroplasty
Mountain Home Research & Education Corporation
Staphylococcal Infections · Methicillin-resistant Staphylococcus Aureus
Initial Treatment for Acute Bacterial Skin Infections (ABSSSI) Caused by Staphylococcus Aureus
PolyMedix, Inc.
Acute Bacterial Skin and Skin-structure Infection(ABSSSI) Due to Staphylococcus Aureus (MSSA) · (Susceptible or Methicillin Resistant)
Outpatient Treatment of Gram Positive Wound Infections in the Diabetic Foot: A Pharmaco-economic Comparison of Daptomycin vs. Vancomycin Based Regimens
Clinical Alliance for Research & Education - Infectious Diseases, LLC.
Diabetic Foot
Study Comparing Cubicin With Vancomycin in Treatment of Participants With Complicated Skin and Skin Structure Infections in a Home Infusion Setting
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Complicated Skin or Skin Structure Infection
Cerebrospinal Fluid Pharmacokinetics of Daptomycin
University of Pittsburgh
Meningitis
Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bacteremia in Renal Impairment
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Complicated Skin and Skin Structure Infections · S. Aureus Bacteremia · Renal Impairment
Study to Compare Efficacy and Safety of Daptomycin in Elderly Patients With Complicated Skin and Soft Tissue Infections
Novartis Pharmaceuticals
Infections
Daptomycin Pharmacokinetics in Continuous Veno-venous Hemodiafiltration
University of Zurich
Bacteremia
Pharmacokinetics (PK) and Safety Evaluation of Daptomycin in Children Ages 3-24 Months With Proven or Suspected Gram-positive Infections or Peri-Operative Subjects Receiving Prophylactic Antibiotics
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Gram Positive Bacterial Infection
An Open Label Study to Describe the Pharmacokinetics of Daptomycin in Infants
Duke University
Sepsis
Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study
University of Zurich
Gram-Positive Bacterial Infections
Study of the Pharmacokinetics of Daptomycin in Children With Renal Disease
University of Oklahoma
Chronic Kidney Disease · Bacterial Infection
Study to Evaluate Daptomycin Given During Dialysis and After Dialysis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
End-stage Renal Disease · Renal Failure Chronic Requiring Hemodialysis
Phase 4 Efficacy and Safety Study of Cubicin® With and Without Combination Therapy in S. Aureus Infective Endocarditis (SAIE)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Infective Endocarditis
Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China
AstraZeneca
Healthy
Daptomycin as Antibiotic Prophylaxis of Sternal Wound Infections
Hannover Medical School
Wound Infection
Phase 2 Study of Safety, Efficacy, and Pharmacokinetics of Higher Doses of Daptomycin and Vancomycin in MRSA Bacteremia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Endocarditis, Bacterial · Infective Endocarditis
China Registration Study in Patients With Skin Infections
AstraZeneca
Skin Diseases · Infectious
A Study of MK-3009 in Japanese Patients With Skin or Blood Stream Infections Caused by Methicillin-resistant Staphylococcus Aureus (MK-3009-002)
Merck Sharp & Dohme LLC
Staphylococcal Infection
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Skin Diseases, Infectious
Pharmacokinetics of Daptomycin During Cardiopulmonary Bypass Surgery
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Late Effects of Surgery · Staphylococcus Aureus · Surgical Site Infection
PK and Safety Evaluation of Daptomycin in Children Ages 2-6 With Proven or Suspected Gram-positive Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Gram Positive Infection · Concurrent Antibiotic Treatment
A Pilot Study of Daptomycin for Antimicrobial Prophylaxis
Duke University
Antimicrobial Prophylaxis
Safety Study to Evaluate Daptomycin in Non-infected Adults Who Are Either on Hemodialysis or Continuous Ambulatory Peritoneal Dialysis (MK-3009-021)
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
End-Stage Renal Disease
Study of Daptomycin in Subjects Undergoing Surgery for Osteomyelitis Associated With an Infected Prosthetic Caused by Staphylococci
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Osteomyelitis
Catheter Related - Gram Positive Bloodstream Infections
M.D. Anderson Cancer Center
Bloodstream Infection
Pharmacokinetics of Daptomycin in Critically Ill Patients Receiving Continuous Venovenous Hemodialysis (CVVHD)
University of Michigan
Critically Ill · Hemodialysis
Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Soft Tissue Infections
Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections
Novartis
Staphylococcal Skin Infections
Daptomycin in Treating Neutropenia and Fever in Patients With Cancer
OHSU Knight Cancer Institute
Fever · Sweating · Hot Flashes · Infection
Daptomycin as an Adjuvant Agent in the Treatment of Enterococcal Native Valve Endocarditis.
Weill Medical College of Cornell University
Endocarditis, Bacterial
Acute Renal Failure in the Surgical Intense Care Units - NTUH-SICU-ARF (NSARF) Study
National Taiwan University Hospital
Acute Renal Failure · Sepsis · Postoperative
Daptomycin in the Treatment of Catheter-Related Staphylococcus Aureus
M.D. Anderson Cancer Center
Staphylococcus Aureus
Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections
Novartis Pharmaceuticals
Skin Diseases, Infectious · Soft Tissue Infections
Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Cellulitis
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Gram-positive Bacterial Infections
Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy
Wake Forest University Health Sciences
Infection · Neutropenia · Unspecified Adult Solid Tumor, Protocol Specific · Unspecified Childhood Solid Tumor, Protocol Specific
Daptomycin for the Treatment of Severe Necrotizing Soft-Tissue Infections
University of Maryland, Baltimore
Fasciitis, Necrotizing · Severe Necrotizing Skin and Soft Tissue Infections · Fournier's Gangrene
Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Soft Tissue Infections
Cubicin(R) for Complicated Post-surgical Wound Infections
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Wound Infections
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Gram-Positive Bacterial Infections
Daptomycin in the Treatment of Subjects With Infective Endocarditis or Bacteremia Due to S. Aureus
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Bacterial Endocarditis · Bacteremia
Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia Due to S. Pneumoniae
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Pneumonia, Bacterial
Comparative Study of Cidecin™ (Daptomycin) to Rocephin® (Ceftriaxone) in the Treatment of Moderate to Severe Community-Acquired Acute Bacterial Pneumonia
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Pneumonia, Bacterial
IIBSP-TDM-2023-28
Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau
Critical Patients admitted to the ICU
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
ZKSJ0165
Friedrich-Schiller-Universitaet Jena
Infectious endocarditis caused by Gram-positive cocci (staphylococci, enterococci, streptococci)
Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.
Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Daptomycin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.